Why Brookdale (BKD) Shares Are Falling Today

Stock Story

Acadia Healthcare

+6.07%

Brookdale Senior Living

What Happened?

Shares of senior living provider Brookdale Senior Living fell 3.8% in the afternoon session after a competitor, Acadia Healthcare (ACHC), significantly cut its 2025 financial outlook, triggering a sell-off across the healthcare facilities sector. Acadia announced that its professional and general liability expenses for 2025 were projected to be about $116 million, more than double the $54 million from 2024. This dramatic increase in costs forced the company to lower its adjusted earnings guidance for 2025 to a range of $1.94 to $2.04 per share, a steep decline from $3.30 in 2024. The news raised concerns that other operators in the industry, like Brookdale, might face similar pressures from rising liability claims. Compounding the issue, an analyst at Cantor Fitzgerald lowered the price target on Acadia's stock from $22.00 to $17.00.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Brookdale? Access our full analysis report here.

What Is The Market Telling Us

Brookdale’s shares are quite volatile and have had 17 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 9 days ago when the stock gained 3.9% on the news that reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help people pay for health insurance, are crucial for insurers as they maintain a stable customer base. An extension would ensure continued revenue for companies with significant exposure to the ACA marketplace. The news prompted a strong positive reaction from investors, with Centene (CNC) shares jumping as much as 8%, Molina Healthcare (MOH) rising over 3%, and Oscar Health (OSCR) soaring 18%. The potential for a two-year extension reduces regulatory uncertainty for the sector, which investors view as a significant positive for the industry's outlook.

Brookdale is up 109% since the beginning of the year, and at $10.58 per share, it is trading close to its 52-week high of $11.25 from November 2025. Investors who bought $1,000 worth of Brookdale’s shares 5 years ago would now be looking at an investment worth $2,431.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Tesla and Netflix among market cap stock movers on Wednesday

Investing.com

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Tesla (TSLA) are rallying, while stocks like Netflix (NFLX) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap:$200 billion USD or higher)

Netflix (NFLX); Comcast (CMCSA) bid to merge NBCUniversal unit with Warner Bros - Bloomberg; -5.97%
Microsoft (MSFT); Microsoft Lowers AI Software Sales Quotas as Customers Resist Newer Products; -2.37%
Micron Tech (MU); -1.95%
Alibaba-exch (BABA); -2.04%
Tesla Motors (TSLA); After AI Push, Trump Administration Is Now Looking To Robots; +2.76%

Large-Cap Stock Movers (Market Cap:$10-$200 billion USD)

Pure Storage Inc (PSTG); Pure Storage posts in-line Q3 earnings, revenue beat; Shares fall 10%; -26.35%
SanDisk Corp-Exch (SNDK); -6.5%
Wayfair Inc (W); Jefferies downgrades Wayfair stock to Hold on valuation concerns; -5.65%
UL Solutions (ULS); UL Solutions announces secondary offering of 12.5 million stocks; -5.37%
Seagate Technology (STX); -5.41%
Marvell Technology Group Ltd (MRVL); Summit Insights upgrades Marvell stock rating to Buy on AI growth outlook; +6.8%
ON Semiconductor (ON); +6.2%
Alcoa (AA); +5.77%
Fiserv Inc (FISV); +4.81%
Microchip Technology Inc (MCHP); Microchip unveils low-power digital monitors for battery devices; +8.64%

Mid-Cap Stock Movers (Market Cap:$2-$10 billion USD)

Gitlab (GTLB); GitLab appoints Jessica Ross as new CFO effective January 2026; -15.03%
Adaptive Biotechnologies Corp (ADPT); -9.5%
Diginex Inc (DGNX); -10.0%
Fermi America LLC (FRMI); -6.66%
ELF Beauty Inc (ELF); +8.05%
dMY Technology Group II (GENI); +8.75%
Regencell Bioscience Holdings (RGC); +8.1%
American Eagle Outfitters (AEO); American Eagle stock soars 11% on strong Q3 results, raised guidance; +13.97%
SeaCube Container Leasing Ltd (BOX); Box Inc stocks plunge over 10% on bottom-line miss in Q3; +7.29%
MTech Acquisition A (ABTC); +6.16%

Small-Cap Stock Movers (Market Cap:$300 million - $2 billion USD)

Ambitions Enterprise Management Co (AHMA); +43.51%
MapLight Therapeutics Inc (MPLT); +26.38%
Anavex Life Sciences (AVXL); +23.21%
InterPrivate Acquisition (AEVA); European automaker selects Aeva as exclusive lidar supplier; +17.4%
Pharvaris BV (PHVS); Pharvaris reports positive phase 3 results for HAE attack treatment; +17.0%
Carbylan Therapeutics Inc (KALV); +17.38%
POET Tech NAQ (POET); +13.93%
TryHard Holdings (THH); -19.71%
Acadia Healthcare (ACHC); Acadia Healthcare stock rating downgraded by BofA on higher insurance costs; -14.68%
Adc Therapeutics SA (ADCT); ZYNLONTA-glofitamab combo shows 90% response rate in lymphoma trial; -29.35%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

Important Notice To Long-Term Shareholders Of Five Below, Inc. (Nasdaq: Five), Molina Healthcare, Inc. (Nyse: Moh), Synopsys, Inc. (Nasdaq: Snps), And Unicycive Therapeutics, Inc. (Nasdaq: Uncy): Grabar Law Office Investigates Claims On Your Behalf

Reuters

Unicycive Therapeutics

-4.74%

Risk Warnings and Disclaimers

Add to Favorites

Marvell, Coinbase and American Eagle rise premarket; Crowdstrike, Okta fall

Investing.com

Investing.com -- U.S. stock futures rose Wednesday ahead of the release of economic data that could add to expectations of a Federal Reserve rate cut next week.

Here are some of the biggest premarket U.S. stock movers today:

Marvell Technology (NASDAQ:MRVL) stock soared 10% after the chipmaker confirmed a multi-billion deal to buy semiconductor startup Celestial AI, as it looks to expand its compute capacity during an ongoing surge in demand driven by the artificial intelligence boom.
Coinbase Global (NASDAQ:COIN) stock rose 2.1% after bitcoin, the world’s most popular cryptocurrency, rebounded from its deep slide at the start of the week, climbing to a two-week high.
Pure Storage (NYSE:PSTG) stock slumped 14% after the flash storage company failed to beat expectations in its latest quarterly results, even as it raised its full-year guidance.
CrowdStrike (NASDAQ:CRWD) stock fell 1.2% despite the cybersecurity firm reporting quarterly results that topped expectations and an upbeat full-year forecast, buoyed by record customer additions, strong subscription growth and rising demand for its AI-linked cybersecurity tools.
Okta (NASDAQ:OKTA) stock dropped 3.9% even after the identity management company reported quarterly results that exceeded expectations, with an upbeat full-year guidance, helped by steady demand from large customers and growing adoption of products tied to identity governance and AI security.
American Eagle Outfitters (NYSE:AEO) stock surged 13% after the clothes retailer raised its comparable sales guidance for the full year and reported net revenue for the third quarter that topped expectations.
Gitlab (NASDAQ:GTLB) stock fell 9.2% despite the software company delivering better-than-expected third-quarter results and lifting full-year revenue guidance.
Acadia Healthcare (NASDAQ:ACHC) stock slumped 28% after the healthcare company revised its fiscal year 2025 guidance downward, raising concerns about the company’s future earnings potential.
Oracle (NYSE:ORCL) stock gained 1.8% after Wells Fargo started coverage of the tech giant with an ‘overweight’ recommendation, describing the firm as an “emerging leader in the AI super-cycle.”

Risk Warnings and Disclaimers

Add to Favorites

Moh - Moh Deadline: Rosen, Leading Investor Counsel, Encourages Molina Healthcare, Inc. Investors To Secure Counsel Before Important December 2 Deadline In Securities Class Action

Reuters

Molina Healthcare

+0.86%

Risk Warnings and Disclaimers

Add to Favorites

Pomerantz LLP Shares Class Action Details With Shareholders in Molina Healthcare, Inc. – MOH

Acceswire

Molina Healthcare

+0.86%

NEW YORK CITY, NY / ACCESS Newswire / December 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") .   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Molina and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until December 2, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Molina securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.        

[Click here for information about joining the class action]

On July 7, 2025, Molina issued a press release announcing financial results for the second quarter of 2025 and slashing full year 2025 adjusted earnings per share guidance. The press release reported second quarter 2025 adjusted earnings of approximately $5.50 per share, which was "below . . . prior expectations" due to "medical cost pressures in all three lines of business." The Company also announced that it "expects these medical cost pressures to continue into the second half of the year" and cut guidance for expected adjusted earnings per share 10.2% at the midpoint, from "at least $24.50 per share" to a "range of $21.50 to $22.50 per share." The press release revealed Molina was experiencing a "short-term earnings pressure" from a "dislocation between premium rates and a medical cost trend which has recently accelerated."

On this news, Molina's stock price fell $6.97 per share, or 2.9%, to close at $232.61 per share on July 7, 2025.

Then, on July 23, 2025, Molina issued a press release reporting its financial results for the second quarter ended June 30, 2025 and further slashing the Company's full-year 2025 earnings guidance. The press release revealed, in part, that the Company's "GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year;" and it "now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share." This represented another 13.6% cut to guidance of earnings per share at the midpoint, from the cut to guidance announced less than two weeks earlier. Molina also cut its guidance for its full year 2025 GAAP net income 27% to $912 million. Molina attributed its results a full year outlook to a "challenging medical cost trend environment," including mere "utilization of behavioral health, pharmacy, and inpatient and outpatient services." The Company claimed that its guidance cut also reflected "new information gained in the quarterly closing process."

On this news, Molina's stock price fell $32.03 per share, or 16.84%, to close at $158.22 per share on July 24, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

SOURCE: Pomerantz LLP

View the original press release on ACCESS Newswire

Risk Warnings and Disclaimers

Add to Favorites